funder-graph

FundersNJ

Grants paid by The Med13l Foundation Inc

EIN 82-2469441 · Park Ridge, NJ · Form 990, Schedule I · NTEE H11

The Med13l Foundation Inc of Park Ridge, NJ (EIN 82-2469441) reported 8 grants paid totaling $449,678 to 6 recipients in tax years 2023–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.

Grants paid

$449,678

8 grants

Recipients

6

distinct organizations

Tax years

2023–2024

2 filings in the corpus

By tax year

Grants by tax year, as the same figures
Tax yearGrants paidAmount paidApproved for future
20234$157,263
20244$292,415

Top recipients

The 6 recipients receiving the most from The Med13l Foundation Inc, by grants paid, out of 6 distinct recipients.

Recipients ranked by total grants paid
RecipientMatchLocationGrantsTotal paidLatest year
Transcripta Bio Inc (fka Rarebase Pbc) 85-2134862APalo Alto, CA2$250,6502024
Rowan University Foundation Inc 22-2482802AGlassboro, NJ1$76,9842024
Vanderbilt University Medical Center 35-2528741ANashville, TN1$46,0002024
State University of Iowa 42-6004813AIowa City, IA1$38,3332023
Combined Brain 83-1825692ABrentwood, TN2$30,5682024
Pacific Immunology 45-0505829ARamona, CA1$7,1432023

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Every grant

All 8 grant rows this organization reported, most recent first.

Grants reported by The Med13l Foundation Inc
Tax yearRecipientMatchAmountTypePurposeSource filing
2024Transcripta Bio Inc (fka Rarebase Pbc) Palo Alto, CAA$164,650paidBIOMARKER DISCOVERY PROJECT AND DRUG DISCOVERY PROJECT USING RAREBASE (NOW TRANSCRIPTA BIO) FUNCTION PLATFORM202533169349300613
2024Rowan University Foundation Inc Glassboro, NJA$76,984paidUNDERSTANDING OF THE ROLE MITOCHONDRIAL DYSFUNCTION PLAYS IN THE PATHOOGY ASSOCIATED WITH MED13L SYNDROME MUTATIONS202533169349300613
2024Vanderbilt University Medical Center Nashville, TNA$46,000paidEXPLORING THE IMPACT OF DISEASE MODIFYING COMPOUNDS IN MED13L PATIENT DERIVE202533169349300613
2024Combined Brain Brentwood, TNA$4,781paidSTRATEGIC RESEARCH PLAN AND BIOSPECIMEN COLLECTION202533169349300613
2023Rarebase Pbc Palo Alto, CAA$86,000paidBIOMARKER DISCOVERY PROJECT AND DRUG DISCOVERY PROJECT USING RAREBASE FUNCTION PLATFORM202423199349309327
2023State University of Iowa Iowa City, IAA$38,333paidPHYSIOLOGICAL AND MOLECULAR SIGNATURES IN MOUSE MODELS OF MED13L SYNDROME202423199349309327
2023Combined Brain Brentwood, TNA$25,787paidSTRATEGIC RESEARCH PLAN AND BIOSPECIMEN COLLECTION202423199349309327
2023Pacific Immunology Ramona, CAA$7,143paidPRODUCTION OF ANTIBODY FOR MED13L202423199349309327

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Source filings

Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.

Returns this page is derived from
FormTax yearPeriod endFiledSchemaIRS OBJECT_ID
99020242024-12-31not stated2024v5.2202533169349300613
99020232023-12-31not stated2023v5.1202423199349309327

Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/822469441.json.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.